Skip to main content
Year archive

CKD Bio Corp. — 2022 filings

All 20 regulatory filings released by CKD Bio Corp. (063160) in 2022, sourced directly from the official regulator.

20 Filings
2022 Period
2022 filings (20)
Filing Released Lang
투자판단관련주요경영사항
Regulatory Filings
2022-11-22 Korean
분기보고서 (2022.09)
Interim / Quarterly Report 9M 2022
2022-11-14 Korean
영업(잠정)실적(공정공시)
Earnings Release Q3 2022
2022-10-28 Korean
반기보고서 (2022.06)
Interim / Quarterly Report H1 2022
2022-08-16 Korean
영업(잠정)실적(공정공시)
Earnings Release Q2 2022
2022-07-29 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-16 Korean
영업(잠정)실적(공정공시)
Earnings Release Q1 2022
2022-04-29 Korean
투자판단관련주요경영사항
Legal Proceedings Report
2022-04-11 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-25 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-17 Korean
사업보고서 (2021.12)
Audit Report / Information FY 2021
2022-03-17 Korean
주주총회소집공고
AGM Information
2022-03-10 Korean
주주총회집중일개최사유신고
AGM Information
2022-03-10 Korean
주주총회소집결의
AGM Information
2022-03-04 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2022-03-04 Korean
투자판단관련주요경영사항
Regulatory Filings
2022-02-25 Korean
투자판단관련주요경영사항
Regulatory Filings
2022-02-09 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2021
2022-01-28 Korean
투자판단관련주요경영사항
Regulatory Filings
2022-01-19 Korean
투자판단관련주요경영사항
Legal Proceedings Report
2022-01-18 Korean